Publications by authors named "Edith Maes"

Claim this Profile
F
Fewer Worsening Heart Failure Events With HeartLogic on top of Standard Care: a Propensity-Matched Cohort Analysis.
Michelle Feijen, Monika Beles, Yan Zhi Tan, Audrey Cordon, Matthias Dupont, Edith Maes

J Card Fail· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Race for COVID-19 Vaccines: Accelerating Innovation, Fair Allocation and Distribution.
Rutger Daems, Edith Maes

Vaccines (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of an ultra-high density mapping system compared to non-ultra-high density mapping systems for radiofrequency catheter ablation procedures in patients with atrial fibrillation.
Bernardo Wise, Ramón Albarrán-Rincón, Alfonso De Lossada Juste, Ane Erkiaga Aio, Armin Klesius, Edith Maes

J Interv Card Electrophysiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients.
Roderick W Treskes, Monika Beles, Maria-Luce Caputo, Audrey Cordon, Eliana Biundo, Edith Maes

ESC Heart Fail· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].
Shazia Sheikh, Eliana Biundo, Soizic Courcier, Oliver Damm, Odile Launay, Edith Maes

Vaccine· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A report on the status of vaccination in Europe.
Shazia Sheikh, Eliana Biundo, Soizic Courcier, Oliver Damm, Odile Launay, Edith Maes

Vaccine· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer.
Esse I H Akpo, Irshaad R Jansen, Edith Maes, Steven Simoens

Front Pharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Making sense of big data in health research: towards an EU action plan.
Charles Auffray, Rudi Balling, Inês Barroso, László Bencze, Mikael Benson, Edith Maes

Genome Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making sense of big data in health research: Towards an EU action plan.
Charles Auffray, Rudi Balling, Inês Barroso, László Bencze, Mikael Benson, Edith Maes

Genome Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical portfolio management: global disease burden and corporate performance metrics.
Rutger Daems, Edith Maes, Maneesha Mehra, Benjamin Carroll, Adrian Thomas

Value Health· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equity in Pharmaceutical Pricing and Reimbursement: Crossing the Income Divide in Asia Pacific.
Rutger Daems, Edith Maes, Christoph Glaetzer

Value Health Reg Issues· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines.
Jacqueline A Keith, Laetitia Agostini Bigger, Phyllis A Arthur, Edith Maes, Rutger Daems

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis